P1224 Predicting response to nutritional therapy in newly diagnosed children with Crohn’s Disease (CD) using multi-omics approach
A Azulay,Y Aharoni Frutkoff,Y Shimhlash,E Borenstein,L Reshef,L Plotkin,G Focht,T Maslov,E Orlanski-Meyer,R Lev-Tzion,O Ledder,D Yogev,A Assa,D Turner
DOI: https://doi.org/10.1093/ecco-jcc/jjad212.1354
2024-01-01
Journal of Crohn's and Colitis
Abstract:Abstract Background Background. One third of children with Crohn's disease (CD) will fail treatment with exclusive enteral nutrition (EEN) but predictors of response have been hitherto lacking. In this prospective cohort study, we aimed to use multiomic data to predict EEN response in treatment-naïve children with CD. Methods Methods. Children commenced on EEN at CD onset were followed through 8 weeks. Stool was collected for microbiome and metabolomics, and serum for metabolomics. Disease indices and clinical data were recorded. Targeted quantitative metabolomics approach was applied to analyze fecal and serum samples using a combination of direct injection mass spectrometry with a reverse-phase LC-MS/MS custom assay. DNA extracted from stool was sequenced and 16S rRNA gene was amplified. Feature selection was first utilized, using Recursive Feature Elimination with Cross-Validation (RFECV). For each omic analysis and the multiomic integration, selected components were fitted into a machine learning random forest (RF) model. Results Results. Included were 51 children (aged 14.8±2.7 yrs) treated with EEN, of whom 34 (66%) were responders; 36 (70%) had serum metabolomics, 20 (39%) fecal metabolomics and 31 (61%) microbiome data while 17 (33%) had all components. Clinical data and standard labs did not predict response (Table). The individual omic models ranked several key metabolites and microbes (Figure) and were able to predict EEN response with an accuracy ranging at 0.806-0.850 (Table). Serum 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (CMPF), fecal phenylethylamine and fecal alpha-aminobutyric acid were higher in non-responders while serum malic acid and fecal 3-methyladipic acid were higher in responders (Fig. A-B). Moreover, levels of Veillonela and Bifidobacterium species alongside Blautia genus were higher in responders while Lachnospiraceae and Fusicatenibacter genus were higher in non-responders (Fig. C). The final multiomic model which included also clinical data, retained components from serum and fecal metabolomics but none from the microbiome; it predicted EEN response with high accuracy of 0.882 (Table). Higher level of serum 2-hydroxyglutraic acid, 2-hydroxy-2-methylbutyric acid and fecal 3-methyladipic acid were detected in responders. In non-responders there were higher level of serum alpha-aminobutyric acid, valeric acid, isovaleric acid, alpha-aminobutyric acid and kynrenine and alongside with increased fecal kynrenine/tryptophan ratio, both part of the tryptophan metabolism and kynrenine pathway (Fig. D). Conclusion Conclusion. In this multi-omic analysis, we generated a,metabolomics-based multiomic model to predict response to EEN, unravelling related biological insights.
gastroenterology & hepatology